What does a pattern of low serum iron, low total iron‑binding capacity, normal ferritin, and transferrin saturation of 12.5% indicate, and how should it be managed?

Anemia of Chronic Disease (ACD) with Possible Functional Iron Deficiency

This laboratory pattern—low serum iron, low TIBC, normal ferritin, and transferrin saturation of 12.5%—most likely indicates anemia of chronic disease (ACD) with possible coexisting functional iron deficiency, and you must evaluate for underlying inflammatory conditions before initiating iron therapy.

Interpretation of Laboratory Pattern

Your patient's iron studies show a distinctive pattern that requires careful interpretation:

• Low serum iron + Low TIBC: This combination is characteristic of ACD/anemia of inflammation, not typical iron deficiency 1
• Normal ferritin: Suggests iron stores are present, though ferritin is an acute-phase reactant and can be falsely elevated by inflammation 1
• Transferrin saturation 12.5%: Below the 16% threshold indicates insufficient iron availability for erythropoiesis 1, 2

The low TIBC is the critical distinguishing feature here. In absolute iron deficiency, TIBC increases as the body attempts to capture more circulating iron. In ACD, TIBC decreases because inflammation suppresses transferrin production 3, 4.

Diagnostic Algorithm

Step 1: Assess for Inflammation

Immediately check inflammatory markers that are independent of iron metabolism:

• C-reactive protein (CRP)
• Erythrocyte sedimentation rate (ESR)
• Complete blood count with differential

1

Step 2: Refine Iron Status Interpretation Based on Inflammation

If inflammation is present (elevated CRP/ESR):

• Your patient likely has ACD, possibly with functional iron deficiency
• The diagnostic criteria for ACD are: ferritin >100 ng/mL AND transferrin saturation <16% 1
• However, ferritin between 30-100 ng/mL with transferrin saturation <16% suggests combined ACD and true iron deficiency 1

If no inflammation is present:

• Transferrin saturation <16% with normal ferritin is unusual
• Consider functional iron deficiency or early absolute iron deficiency
• Ferritin <30 ng/mL would definitively indicate iron deficiency 1

Step 3: Identify Underlying Cause

Search systematically for conditions causing ACD:

• Chronic kidney disease: Check GFR; anemia common when GFR <60 mL/min/1.73m² 4, 5, 2
• Chronic heart failure: Present in 40-70% of CHF patients 5, 2
• Inflammatory bowel disease: Iron deficiency affects 13-90% of IBD patients 1, 2
• Malignancy: Iron deficiency in 18-82% of cancer patients 3, 2
• Chronic infections or autoimmune conditions
• Occult blood loss: Gastrointestinal evaluation if indicated 2

Management Strategy

Treat the Underlying Condition First

The primary intervention for ACD is treating the underlying inflammatory disease 1. Addressing inflammation alone rarely normalizes hemoglobin but is essential 1.

Iron Supplementation Decision Tree

For patients WITHOUT chronic inflammatory conditions:

• Trial of oral iron (ferrous sulfate 325 mg daily or alternate days) 2, 6
• Reassess in 4-8 weeks; hemoglobin should increase 1-2 g/dL 7

For patients WITH chronic inflammatory conditions (CKD, CHF, IBD, cancer):

• Intravenous iron is preferred over oral iron 5, 7, 2, 6
• Oral iron absorption is impaired in inflammatory states 1, 5
• IV iron can overcome the hepcidin-mediated iron blockade 5

Specific to CKD patients:

• Absolute iron deficiency defined as transferrin saturation ≤20% with ferritin ≤100 ng/mL (predialysis/peritoneal dialysis) or ≤200 ng/mL (hemodialysis) 4, 5
• Functional iron deficiency occurs when transferrin saturation <20% despite ferritin 100-700 ng/mL 4
• Consider trial of IV iron (50-125 mg weekly for 8-10 doses); if no response, suspect inflammatory block 4

Specific to CHF patients:

• Iron deficiency defined as ferritin <100 ng/mL and/or transferrin saturation <20% 5
• IV iron improves outcomes even in functional iron deficiency 5, 7

Common Pitfalls to Avoid

1. Don't rely on ferritin alone in inflammatory states: Ferritin is an acute-phase reactant and can be falsely normal or elevated despite true iron deficiency 1, 8

2. Don't miss functional iron deficiency: Patients can have adequate iron stores (normal/high ferritin) but insufficient iron mobilization for erythropoiesis (low transferrin saturation) 4, 5

3. Don't give oral iron to patients with chronic inflammation: It's poorly absorbed and unlikely to be effective 5, 6

4. Don't check iron parameters within 4 weeks of IV iron administration: Circulating iron interferes with assays, producing spurious results 7

5. Don't stop at iron replacement: Always identify and treat the underlying cause of anemia 1, 2

Advanced Testing if Diagnosis Remains Unclear

If standard iron parameters are discordant or confusing:

• Soluble transferrin receptor (sTfR): Elevated in true iron deficiency, normal/low in ACD 1, 9, 10
• Reticulocyte hemoglobin content (CHr) or equivalent (RET-He): Direct assessment of functional iron availability; <28 g/dL suggests iron deficiency 7, 6
• Percentage of hypochromic red blood cells: >10% indicates iron deficiency 4, 6

These tests are particularly useful when ferritin is 30-100 ng/mL with low transferrin saturation, suggesting mixed ACD and iron deficiency 1.

Monitoring After Treatment

Recheck laboratories 4-8 weeks after initiating therapy:

• Complete blood count
• Iron parameters (ferritin, transferrin saturation)
• Inflammatory markers if initially elevated

Target ferritin ≥50 ng/mL (without inflammation) or ≥100 ng/mL (with inflammation) and transferrin saturation ≥20% 1, 7.